Gooch & Housego (GHH) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
2 Jun, 2026Executive summary
Revenue for H1 2026 rose 15.5% year-over-year to £81.9m, with organic constant currency growth of 9.1%, driven by strong aerospace and defense demand and early signs of semiconductor recovery.
Adjusted operating profit increased 16.9% to £7.2m, with margin growth supported by operational improvements and strategic acquisitions.
Order book reached a record £167.3m, up 16.5% from September 2025, providing near full revenue cover for FY2026.
Integration of Phoenix Optical and Global Photonics is largely complete, delivering commercial synergies and expanded capacity.
Full-year expectations remain unchanged, with strong prospects for profitable growth despite macroeconomic and geopolitical risks.
Financial highlights
Organic revenue growth was 9.1% at constant currency, with reported growth at 15.5%.
Gross margin declined by 100bps to 29.4% due to mix headwinds and supply shortages, notably germanium.
Adjusted profit before tax rose 13.9% to £5.8m; adjusted EPS increased to 16.4p.
Net cash from operations improved to £3.9m; net debt (excluding leases) increased to £36.6m, leverage at 1.5x.
Interim dividend maintained at 4.9p per share.
Outlook and guidance
Order intake reached a record £100.3m in H1 2026; order book at £167.3m provides near full cover for FY2026 revenue.
Semiconductor market recovery is underway; strong multi-year demand in A&D optical systems.
Life Sciences production and supply chain disruptions expected to ease in H2 2026.
FY2026 expectations unchanged; positive medium-term outlook despite macroeconomic and geopolitical risks.
Board confident in achieving mid-teens returns over the medium term.
Latest events from Gooch & Housego
- Revenue up 9.1% and order book up 16.5%, with strong Aerospace and Defence demand.GHH
Q2 2026 TU9 Apr 2026 - Revenue up, profit down; strong order book and A&D/Life Sciences offset industrial weakness.GHH
H2 202411 Mar 2026 - Revenue and profit fell, but improved margins and a strong order book support a positive outlook.GHH
H1 202411 Mar 2026 - Acquisition creates a U.S. optical systems hub, boosting defense capabilities and growth potential.GHH
M&A announcement11 Mar 2026 - Revenue and profit surged, led by A&D and Life Sciences, with strong order cover for FY2025.GHH
H1 202511 Mar 2026 - Double-digit revenue and profit growth driven by A&D and acquisitions, with a record order book.GHH
H2 202511 Mar 2026 - Solid FY2024 results and acquisitions set the stage for growth in Life Sciences and Defence.GHH
Investor presentation11 Mar 2026 - Order book grew to £126.4M, driven by innovation, acquisitions, and operational improvements.GHH
AGM 2025 presentation11 Mar 2026 - Double-digit revenue growth and record order intake driven by A&D and new technology focus.GHH
AGM 2026 presentation11 Mar 2026